This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

CHPA Statement On Statewide Indiana Consumer Poll

WASHINGTON, March 4, 2013 /PRNewswire/ -- The Consumer Healthcare Products Association (CHPA) released the following statement today on a recent poll of Indiana voters conducted by The Polling Company and supported by CHPA. The poll, which surveyed 607 Hoosiers on February 4-6 th, found that a 65 percent majority of Hoosiers opposed changing state law to require a doctor's prescription for cold and allergy medicines containing the decongestant pseudoephedrine (PSE).  The poll also found that 84 percent of respondents report they use PSE-containing medicines to treat common symptoms.

"The new Indiana survey is very important because in recent months, well-intentioned lawmakers have proposed legislation that would make it difficult for law-abiding Hoosiers to access the nonprescription medicines they know and trust," said Carlos Gutierrez, senior director of state government affairs for CHPA. "Clearly these proposals do not have the support of Indiana voters, many of whom sufferer from frequent cold and allergy symptoms. While we support efforts to combat the illegal sales of pseudoephedrine, lawmakers should advance solutions that target criminals, not honest citizens. To that end, CHPA is doing everything possible to help Senator Carlin Yoder garner support for his commonsense anti-meth bill, SB 496. Senator Yoder's bill would enhance the state's electronic PSE tracking system, implement stiffer penalties for meth-related crime, and apply sensible PSE purchasing limits."

Key findings from the poll:  

  • 84% of Hoosiers report they rely on the over-the-counter medicines containing pseudoephedrine that would be impacted by changing the law to require a doctor's prescription.
  • A 65%-majority of Hoosiers opposed changing the law to require a doctor's prescription for the purchase of cold and allergy medicines containing pseudoephedrine.  This total included 52% that STRONGLY opposed new rules for pseudoephedrine medicines that are currently sold over-the-counter.  In contrast, 29% of voters supported the new law.
  • By a 59%-35% spread, voters were more likely to agree "it is not worth inconveniencing, or possibly criminalizing law-abiding Hoosiers who benefit from over-the-counter cold or allergy medicines" than that "the benefits would outweigh the inconvenience or cost of a new law."
  • A 65%-majority were "less supportive" toward changing the law knowing that it could increase costs to taxpayers, as uninsured Hoosiers would have to visit emergency rooms to get prescriptions for these medicines.

CHPA is the 132-year-old-trade association representing U.S. manufacturers and distributors of over-the-counter medicines and dietary supplements.

chpa-info.org

SOURCE Consumer Healthcare Products Association

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,102.78 +78.72 0.44%
S&P 500 2,117.29 +9.00 0.43%
NASDAQ 5,024.5940 +19.2030 0.38%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs